Carboxypeptidase A6 Promotes the Proliferation and Migration of Hepatocellular Carcinoma by Up-regulating AKT Signaling Pathway.
In conclusion, our study revealed that CPA6 could promote HCC cell proliferation and migration via AKT-mediated signaling pathway. These findings suggest that CPA6 is a promising diagnostic biomarker and therapeutic target to improve the prognosis of HCC.
PMID: 31612389 [PubMed - in process]
Source: Epilepsy Curr - Category: Neurology Authors: Huang QB, Zhang HW, Liao ZB Tags: Curr Med Sci Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Epilepsy | Hepatocellular Carcinoma | Liver Cancer | Neurology | Study